[Federal Register Volume 70, Number 184 (Friday, September 23, 2005)]
[Notices]
[Pages 55959-55960]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-18994]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Proposed Collection; Comment Request for Form 8820

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Department of the Treasury, as part of its continuing 
effort to reduce paperwork and respondent burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995, Public Law 104-13 (44 U.S.C. 
3506(c)(2)(A)). Currently, the IRS is soliciting comments concerning 
Form 8820, Orphan Drug Credit.

DATES: Written comments should be received on or before November 22, 
2005 to be assured of consideration.

ADDRESSES: Direct all written comments to Glenn Kirkland, Internal 
Revenue Service, room 6512, 1111 Constitution Avenue, NW., Washington, 
DC 20224.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the form and instructions should be directed to Larnice Mack 
at Internal Revenue Service, room 6512,

[[Page 55960]]

1111 Constitution Avenue, NW., Washington, DC 20224, or at (202) 622-
3179, or through the Internet at (<a href="/cdn-cgi/l/email-protection#256944574b4c46400b6844464e654c57560b424a53"><span class="__cf_email__" data-cfemail="612d00130f0802044f2c00020a210813124f060e17">[email protected]</span></a>).

SUPPLEMENTARY INFORMATION:
    Title: Orphan Drug Credit.
    OMB Number: 1545-1505.
    Form Number: 8820.
    Abstract: Filers use this form to elect to claim the orphan drug 
credit, which is 50% of the qualified clinical testing expenses paid or 
incurred with respect to low or unprofitable drugs for rare diseases 
and conditions, as designated under section 526 of the Federal Food, 
Drug, and Cosmetic Act.
    Current Actions: There are no changes being made to the form at 
this time.
    Type of Review: Extension of a currently approved collection.
    Affected Public: Business or other for-profit organizations.
    Estimated Number of Respondents: 100.
    Estimated Time per Respondent: 7 hours, 37 minutes.
    Estimated Total Annual Burden Hours: 762.
    The following paragraph applies to all of the collections of 
information covered by this notice:
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless the collection of 
information displays a valid OMB control number. Books or records 
relating to a collection of information must be retained as long as 
their contents may become material in the administration of any 
internal revenue law. Generally, tax returns and tax return information 
are confidential, as required by 26 U.S.C. 6103.
    Request for Comments: Comments submitted in response to this notice 
will be summarized and/or included in the request for OMB approval. All 
comments will become a matter of public record. Comments are invited 
on: (a) Whether the collection of information is necessary for the 
proper performance of the functions of the agency, including whether 
the information shall have practical utility; (b) the accuracy of the 
agency's estimate of the burden of the collection of information; (c) 
ways to enhance the quality, utility, and clarity of the information to 
be collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information.

    Approved: September 14, 2005.
Glenn Kirkland,
IRS Reports Clearance Officer.
[FR Doc. 05-18994 Filed 9-22-05; 8:45 am]
BILLING CODE 4830-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>